Overview

Quetiapine in Social Anxiety Disorder

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effectiveness and tolerability of quetiapine for the treatment of social anxiety disorder (SAD). The hypothesis is that quetiapine will be effective and well-tolerated for patients with social anxiety disorder.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate